A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation

被引:0
|
作者
Yoshifumi Sonobe
Jihad Aburas
Gopinath Krishnan
Andrew C. Fleming
Ghanashyam Ghadge
Priota Islam
Eleanor C. Warren
Yuanzheng Gu
Mark W. Kankel
André E. X. Brown
Evangelos Kiskinis
Tania F. Gendron
Fen-Biao Gao
Raymond P. Roos
Paschalis Kratsios
机构
[1] University of Chicago Medical Center,Department of Neurology
[2] University of Chicago Medical Center,The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior
[3] University of Chicago,Department of Neurobiology
[4] University of Chicago,Department of Neurology
[5] University of Massachusetts Medical School,The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine
[6] Northwestern University,Institute of Clinical Sciences
[7] MRC London Institute of Medical Sciences,Department of Neuroscience
[8] Imperial College London,undefined
[9] Neuromuscular & Movement Disorders,undefined
[10] Biogen,undefined
[11] Mayo Clinic,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A hexanucleotide repeat expansion GGGGCC in the non-coding region of C9orf72 is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxic dipeptide repeats (DPRs) are synthesized from GGGGCC via repeat-associated non-AUG (RAN) translation. Here, we develop C. elegans models that express, either ubiquitously or exclusively in neurons, 75 GGGGCC repeats flanked by intronic C9orf72 sequence. The worms generate DPRs (poly-glycine-alanine [poly-GA], poly-glycine-proline [poly-GP]) and poly-glycine-arginine [poly-GR]), display neurodegeneration, and exhibit locomotor and lifespan defects. Mutation of a non-canonical translation-initiating codon (CUG) upstream of the repeats selectively reduces poly-GA steady-state levels and ameliorates disease, suggesting poly-GA is pathogenic. Importantly, loss-of-function mutations in the eukaryotic translation initiation factor 2D (eif-2D/eIF2D) reduce poly-GA and poly-GP levels, and increase lifespan in both C. elegans models. Our in vitro studies in mammalian cells yield similar results. Here, we show a conserved role for eif-2D/eIF2D in DPR expression.
引用
收藏
相关论文
共 50 条
  • [41] Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study
    Wiesenfarth, Maximilian
    Huppertz, Hans-Juergen
    Dorst, Johannes
    Lule, Dorothee
    Ludolph, Albert C.
    Mueller, Hans-Peter
    Kassubek, Jan
    NEUROIMAGE-CLINICAL, 2023, 39
  • [42] Characterization of a Family With c9FTD/ALS Associated With the GGGGCC Repeat Expansion in C9ORF72
    Savica, Rodolfo
    Adeli, Anahita
    Vemuri, Prashanthi
    Knopman, David S.
    DeJesus-Hernandez, Mariely
    Rademakers, Rosa
    Fields, Julie A.
    Whitwell, Jennifer
    Jack, Clifford R., Jr.
    Lowe, Val
    Petersen, Ronald C.
    Boeve, Bradley F.
    ARCHIVES OF NEUROLOGY, 2012, 69 (09) : 1164 - 1169
  • [43] Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
    Kumar, Vijay
    Hasan, Gulam M.
    Hassan, Md. Imtaiyaz
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [44] How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD
    van't Spijker, Heleen M.
    Almeida, Sandra
    GENE, 2023, 858
  • [45] ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD
    Park, Jumin
    Lee, Jongbo
    Kim, Ji-hyung
    Lee, Jongbin
    Park, Heeju
    Lim, Chunghun
    NUCLEIC ACIDS RESEARCH, 2021, 49 (19) : 11294 - 11311
  • [46] C9orf72 Hypermethylation Influences Repeat Expansion Associated Pathology in ALS/FTD
    Liu, Elaine
    Russ, Jenny
    Wu, Kathryn
    Neal, Donald
    Suh, Eunran
    McNally, Anna
    Irwin, David
    Van Deerlin, Vivianna
    Lee, Edward B.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 620 - 620
  • [47] Multimodal imaging analysis of C9orf72-associated FTD in the Genetic Frontotemporal dementia Initiative (GENFI) study
    Bocchetta, M.
    Toussaint, N.
    Hutel, M.
    Modat, M.
    Cardoso, M. J.
    Gordon, E.
    Dick, K. M.
    Cash, D. M.
    van Swieten, J.
    Borroni, B.
    Galimberti, D.
    Masellis, M.
    Graff, C.
    Tagliavini, F.
    Frisoni, G. B.
    Laforce, R., Jr.
    Finger, E.
    de Mendonca, A.
    Sorbi, S.
    Warren, J. D.
    Ourselin, S.
    Rohrer, J. D.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 245 - 245
  • [48] Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
    Ash, Peter E. A.
    Bieniek, Kevin F.
    Gendron, Tania F.
    Caulfield, Thomas
    Lin, Wen-Lang
    DeJesus-Hernandez, Mariely
    van Blitterswijk, Marka M.
    Jansen-West, Karen
    Paul, Joseph W., III
    Rademakers, Rosa
    Boylan, Kevin B.
    Dickson, Dennis W.
    Petrucelli, Leonard
    NEURON, 2013, 77 (04) : 639 - 646
  • [49] Testing reversibility of pathology in a new in vitro model for C9orf72 ALS/FTD
    Riemslagh, F.
    Hukema, R.
    Nanhoe, S.
    den Hollander, C.
    de Boer, H.
    van Swieten, J.
    Willemsen, R.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 237 - 237
  • [50] Frequency and Phenotypes Associated with C9ORF72 Repeat Expansions in French FTD and FTD-ALS Patients
    Le Ber, Isabelle
    Camuzat, Agnes
    Guillot-Noel, Lena
    Habert, Marie-Odile
    Hannequin, Didier
    Seilhean, Danielle
    Lacomblez, Lucette
    Golfier, Veronique
    Puel, Michele
    Deramecourt, Vincent
    Martinaud, Olivier
    Millecamps, Stephanie
    Vercelletto, Martine
    Couratier, Philippe
    Sellal, Francois
    Pasquier, Florence
    Salachas, Francois
    Thomas-Anterion, Catherine
    Didic, Mira
    Pariente, Jeremie
    Blanc, Frederic
    Mondon, Karl
    Michel, Bernard-Francois
    Berger, Eric
    Sauvee, Mathilde
    Campion, Dominique
    Meininger, Vincent
    Duyckaerts, Charles
    Guedj, Eric
    Dubois, Bruno
    Brice, Alexis
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 82 - 83